Background: As clinical signs of EOBI and NBI are unspecific, a sensitive and specific laboratory tool is needed for the diagnosis .Aim: To evaluate IL-8 as a marker for presumed EOBI or NBI .Subjects/method: IL-8 and CrP were evaluated on admission in 257 neonates (22-42 weeks of gestation) with clinical signs of EOBI or a history of amniotic infection and 125 times beyond the first week of lifeat the onset of clinical symptoms suggesting NBI in 59 PI (23-35 wk. Gest.). The diagnosis of infection was based on the presence of clinical symptoms and either a positive blood culture or a CrP > 10mg/1 at 24 - 48 hrs after the first blood sample. Results: At cutoffs of IL-8 > 70 pg/ml and CrP > 10 mg/1 sensitivities (Se.) and specificities (Sp.) are shown for IL-8, CrP and the combination of IL-8 > 70pg/ml and/or CrP > 10mg/1. EOBI: Se.: 71%, 40%, 86%, Sp.: 78%, 98%, 78%,. Positive Predictive Value for EOBI: 42%, 86%, 47%. NBI: Se.: 76%, 41%, 88%. Sp.: 92%, 98%, 89%. PPV for NBI: 73%, 85%, 72%. Conclusion: The combination of IL-8 and CrP is a sensitive and specific test for the early diagnosis of both EOBI and NBI in neonates.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Franz, A., Steinbach, G. & Pohlandt, F. Interleukin 8 (Il-8) Is A Sensitive and Specific Marker for Early Onset Neonatal Bacterial Infection (Eobi) and Nosocomial Bacterial Infection (Nbi) in Preterm Infants (Pi). Pediatr Res 42, 401 (1997). https://doi.org/10.1203/00006450-199709000-00116
Issue Date:
DOI: https://doi.org/10.1203/00006450-199709000-00116